MFG
ABBV icon

Merit Financial Group’s AbbVie ABBV Stock Holding History

Merit Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
108,653
+3,743
+4% +$805K 0.17% 107
2026
Q1 		$22.8M Buy
104,910
+11,615
+12% +$2.58M 0.17% 106
2025
Q4 		$21.3M Buy
93,295
+11,253
+14% +$2.56M 0.17% 103
2025
Q3 		$19M Buy
82,042
+2,461
+3% +$501K 0.17% 103
2025
Q2 		$14.8M Buy
79,581
+20,548
+35% +$3.82M 0.16% 100
2025
Q1 		$12.4M Buy
59,033
+9,807
+20% +$1.91M 0.19% 92
2024
Q4 		$8.75M Buy
49,226
+1,375
+3% +$253K 0.16% 119
2024
Q3 		$9.45M Buy
47,851
+1,163
+2% +$217K 0.21% 82
2024
Q2 		$8.01M Buy
46,688
+2,399
+5% +$397K 0.18% 96
2024
Q1 		$7.25M Buy
44,289
+18,522
+72% +$3.19M 0.17% 101
2023
Q4 		$3.99M Sell
25,767
-14,814
-37% -$2.16M 0.12% 119
2023
Q3 		$6.05M Buy
40,581
+2,151
+6% +$316K 0.2% 80
2023
Q2 		$5.18M Buy
38,430
+7,149
+23% +$1.05M 0.17% 93
2023
Q1 		$4.99M Sell
31,281
-1,804
-5% -$276K 0.18% 87
2022
Q4 		$5.35M Buy
33,085
+1,634
+5% +$251K 0.19% 78
2022
Q3 		$4.22M Sell
31,451
-8,039
-20% -$1.15M 0.18% 75
2022
Q2 		$6.05M Buy
39,490
+25,753
+187% +$3.94M 0.19% 77
2022
Q1 		$2.23M Buy
13,737
+842
+7% +$122K 0.13% 97
2021
Q4 		$1.75M Sell
12,895
-217
-2% -$25.6K 0.17% 65
2021
Q3 		$1.41M Buy
13,112
+108
+0.8% +$12.3K 0.15% 74
2021
Q2 		$1.47M Buy
13,004
+40
+0.3% +$4.5K 0.14% 75
2021
Q1 		$1.4M Buy
12,964
+956
+8% +$102K 0.15% 71
2020
Q4 		$1.29M Buy
12,008
+2,001
+20% +$192K 0.12% 68
2020
Q3 		$876K Buy
10,007
+1,773
+22% +$167K 0.08% 96
2020
Q2 		$808K Buy
8,234
+1,247
+18% +$110K 0.08% 93
2020
Q1 		$532K Buy
6,987
+256
+4% +$21.8K 0.06% 118
2019
Q4 		$596K Buy
+6,731
New +$559K 0.05% 122

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Merit Financial Group's ABBV Position: Q2 2026 in Review

Merit Financial Group increased its AbbVie (ABBV) stake by 3.6% in Q2 2026, buying an estimated $805K and bringing the position to 108,653 shares worth $27.3M. The position accounts for 0.17% of the portfolio, ranked #107.

Merit Financial Group first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Merit Financial Group held 108,653 shares of AbbVie worth $27.3M as of Q2 2026.
  • Merit Financial Group bought 3,743 AbbVie shares in Q2 2026, an estimated $805K.
  • AbbVie made up 0.17% of Merit Financial Group's portfolio in Q2 2026, its #107 holding.
  • Merit Financial Group first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.